Protein profile

PA0044

exoenzyme T

Genome: NC_002516.2

Gene: PA0044 exoT Structure source: Experimental + AlphaFold UniProt Q9I788
Amino acids 457
Annotations 6
Features 25
PDB binders 3
Druggability 0.481

Overview

Basic information about this protein and its source genome.

Accession
PA0044
Gene
PA0044 exoT
Status
annotated
Amino acids
457
Structure source
Experimental + AlphaFold

Target profile

Computed evidence for target prioritization.

Human off-target
No hit
Gut microbiome off-target
hit
Essential (DEG)
N
Localization
Extracellular

Selected Druggability evidence

Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.

FPocket 0.481
Structure
Pocket

Sequence

Primary amino-acid sequence viewer.

Functional Annotations

Enzyme classification and Gene Ontology terms linked to this protein.

6 GO

Gene Ontology (GO)

6
  • GO:0005576 The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
  • GO:0005096 Binds to and increases the activity of a GTPase, an enzyme that catalyzes the hydrolysis of GTP.
  • GO:0106274 Catalysis of the reaction: L-arginyl-[protein] + NAD+ = H+ + (ADP-D-ribosyl)-L-arginyl-[protein] + nicotinamide.
  • GO:0016779 Catalysis of the transfer of a nucleotidyl group from one compound (donor) to another (acceptor).
  • GO:0090729 Interacting selectively with one or more biological molecules in another (target) organism, initiating pathogenesis (leading to an abnormal, generally detrimental state) in the target organism. The activity should refer to an evolved function of the active gene product, i.e. one that was selected for. Examples include the activity of botulinum toxin, and snake venom.
  • GO:0141029 A process in which a symbiont alters or subverts focal adhesion in its host. The host is defined as the larger of the organisms involved in a symbiotic interaction.

Sequence Features

Domain/signature hits from InterPro and related databases.

25 records
Show feature table
Start End DB Term Name
246 432 Pfam PF03496 ADP-ribosyltransferase exoenzyme
246 432 InterPro IPR003540 ADP ribosyltransferase
242 418 ProSiteProfiles PS51996 Toxin-related mono-ADP-ribosyltransferase (TR mART) core domain profile.
230 427 SUPERFAMILY SSF56399 ADP-ribosylation
98 232 Gene3D G3DSA:1.20.120.260 Virulence factor YopE uncharacterised domain
98 232 InterPro IPR037168 Virulence factor YopE, GAP domain superfamily
28 77 Gene3D G3DSA:6.10.250.2690 -
66 455 PANTHER PTHR10339 ADP-RIBOSYLTRANSFERASE
108 227 CDD cd00219 ToxGAP
108 227 InterPro IPR014773 Virulence factor YopE, GAP domain
238 410 Gene3D G3DSA:3.90.176.10 -
100 231 SUPERFAMILY SSF47233 Bacterial GAP domain
100 231 InterPro IPR037168 Virulence factor YopE, GAP domain superfamily
132 201 Pfam PF03545 Yersinia virulence determinant (YopE)
132 201 InterPro IPR014773 Virulence factor YopE, GAP domain
39 56 PRINTS PR01372 Yersinia virulence determinant YopE protein signature
39 56 InterPro IPR003537 Type III secretion system effector protein YopE-like
23 36 PRINTS PR01372 Yersinia virulence determinant YopE protein signature
23 36 InterPro IPR003537 Type III secretion system effector protein YopE-like
215 232 PRINTS PR01372 Yersinia virulence determinant YopE protein signature
215 232 InterPro IPR003537 Type III secretion system effector protein YopE-like
181 199 PRINTS PR01372 Yersinia virulence determinant YopE protein signature
181 199 InterPro IPR003537 Type III secretion system effector protein YopE-like
132 149 PRINTS PR01372 Yersinia virulence determinant YopE protein signature
132 149 InterPro IPR003537 Type III secretion system effector protein YopE-like

3D Structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.

3D visualization script Full viewer

Loading 3D structure...

Legend High Medium Low

Structural evidence

3 + 1

Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
PDB 6GNN
X-ray 3.79 Å C
48.8% 235-457
Viewing
PDB 6JNP
X-ray 2.26 Å A,D
12.5% 23-79
Loaded
PDB 4JMF
X-ray 2.10 Å A
10.9% 28-77
Loaded
AlphaFold PA0044
AlphaFold full sequence Loaded
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

53 records

Highest-confidence structural evidence: ligands co-crystallized with this exact protein. If the source PDB is loaded in TPW, use Open crystal to inspect it in the structure viewer.

Show only:
Ligand Source crystal MW · LogP · TPSA Lipinski PAINS SMILES
F4W 264.3 Da LogP 1.49 TPSA 83.0 ✓ Ro5 ✓ Clean C1Cc2c(sc3c2C(=O)NC(=N3)CCC(=O)O)C1

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.